research
Department announces new grants, publications
Department faculty have been awarded three grants. In addition, our researchers’ work has generated dozens of manuscript publications. New GrantsPI: Scott CampbellTitle: Dataset of electronic health records for N3C Clinical enclave according to the NCATS DUASponsor: Axle InformaticsAmount: $65,146 (direct)Time Frame: 10/2024 through 9/2029 PI: Scott KoepsellTitle: Validation of the Clinical Performance of Hemosil CL […]
Apr 8, 2025
Hematopathology fellow researching rare form of lymphoma
A rare chromosomal abnormality found in some forms of lymphoma is getting a closer look at the University of Nebraska Medical Center. Ahmed Sabri, MD, a hematopathology fellow in the Department of Pathology, Microbiology and Immunology, is performing cytogenetic and molecular analysis of t(9;14)(p13;q32) lymphomas with his mentor faculty, Arash Ronaghy, MD, PhD. “We know […]
Mar 27, 2025
Clinical microbiology fellow studying ways to characterize central line-associated bloodstream infections
Chunyi Zhou, MD, PhD, a second-year clinical microbiology fellow in UNMC’s Department of Pathology, Microbiology and Immunology, is studying whether whole genome sequencing can be a useful tool to characterize S. epidermidis isolates that are associated with central line-associated bloodstream infections (CLABSIs).
Mar 19, 2025
Dr. Jana Broadhurst is part of team honored at 2024 Innovation Awards
Learn more about the project Dr. Broadhurst was involved with in this write-up from UNeMed.
Nov 21, 2024
Itidal Reslane and Gabrielle Watson named UNMC Graduate Students of Distinction
Both students, who are PhD candidates in IGPBS – Immunology, Pathology, and Infectious Disease, were honored after being awarded fellowships from the American Heart Association. Learn more from the Office of Graduate Studies.
Nov 15, 2024
Dr. Sturd publishes a first author manuscript in mSphere
Chlamydia trachomatis is a leading cause of sexually transmitted infections worldwide. As an obligate intracellular pathogen, it has been selected to establish a niche within the host cell in a membrane-derived vacuole called the chlamydial inclusion. Chlamydial proteins recruit host proteins to the chlamydial inclusion that are critical for infection development. Two of these host-derived […]
Nov 1, 2024
Immunoscape
Zachary Van Roy, an MD/PhD trainee in the laboratory of Dr. Tammy Kielian, has indeed had a very productive month as he has published two first author manuscripts in Nature Communication and Cell Reports Medicine. The Cell Reports Medicine manuscript, which he co-first authored with Drs. Gunjan Kak and Lee Korshoj, is the first to […]
Nov 1, 2024
Department announces grants, publications
Department faculty have been awarded two grants. In addition, our researchers’ work has generated 30 manuscript publications. New grants PI: Scott Koepsell MDSupport of the studies and procedures to be performed to support standardization of the Teucer’s Podocin RT-qPCR assay. Teucer Biotech Inc. PI: Joshua Santarpia PhDOctopus FY24. National Strategic Research Institute Publications (November 2024-current): […]
Nov 1, 2024
Dr. Abdalla receives Research Scholar Grant from the American Cancer Society
Pancreatic ductal adenocarcinoma (PDAC) is asymptomatic and metastasizes early, leading to a meager 5-year survival rate of ~7%. Chemotherapy has had limited success in extending the life span of patients with advanced PDAC. Dr. Abdalla and his group are extending their expertise in reactive oxygen species by hypothesizing that inhibition of heme oxygenase in combination with […]
Nov 1, 2024
Dr. Fisher receives R37 Merit Award from the National Cancer Institute
Patients with metastatic chemotherapy have a 5 year survival rate of 14% with is exacerbated by K-Ras mutations. Previous work by Dr. Fisher and his team have shown that K-Ras muations increase the transcriptional co-activator PGC-1-b. Thus the goal of this application is to develop novel therapies for metastatic disease that inhibit PGC-1-b. No current, […]
Nov 1, 2024
